UA6099A1 - Method for determination of individual sensitivity of patients with bronchial asthma to timaline - Google Patents

Method for determination of individual sensitivity of patients with bronchial asthma to timaline

Info

Publication number
UA6099A1
UA6099A1 UA4460444A UA4460444A UA6099A1 UA 6099 A1 UA6099 A1 UA 6099A1 UA 4460444 A UA4460444 A UA 4460444A UA 4460444 A UA4460444 A UA 4460444A UA 6099 A1 UA6099 A1 UA 6099A1
Authority
UA
Ukraine
Prior art keywords
patients
determination
bronchial asthma
timaline
individual sensitivity
Prior art date
Application number
UA4460444A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Любов Соломонівна Когосова
Любовь Соломоновна Когосова
Микола Микитович Коваленко
Николай Никитович Коваленко
Катерина Федорівна Чернушенко
Екатерина Федоровна Чернушенко
Олександр Юхимович Марков
Александр Ефимович Марков
Сусана Ісаівна Гончарова
Сусана Исаевна Гончарова
Original Assignee
Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського
Украинский научно-исследовательский институт фтизиатрии и пульмонологии им.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського, Украинский научно-исследовательский институт фтизиатрии и пульмонологии им. filed Critical Український Науково-Дослідний Інститут Фтизіатрії І Пульмонології Ім. Акад. Ф.Г. Яновського
Priority to UA4460444A priority Critical patent/UA6099A1/en
Publication of UA6099A1 publication Critical patent/UA6099A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Determination of individual sensitivity of patients with bronchial asthma to timeline is carried out through setting reaction Ea-ROK in presence of timeline in dose of 20 mkg/ml. Reaction Ea-ROK is additionally performed with doses 0.2-2.0 mkg/ml and at presence of positive reaction with all doses or two of those, or one of those, one determines sensitivity of body to minimal dose of preparation.
UA4460444A 1988-07-14 1988-07-14 Method for determination of individual sensitivity of patients with bronchial asthma to timaline UA6099A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA4460444A UA6099A1 (en) 1988-07-14 1988-07-14 Method for determination of individual sensitivity of patients with bronchial asthma to timaline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA4460444A UA6099A1 (en) 1988-07-14 1988-07-14 Method for determination of individual sensitivity of patients with bronchial asthma to timaline

Publications (1)

Publication Number Publication Date
UA6099A1 true UA6099A1 (en) 1994-12-29

Family

ID=74575234

Family Applications (1)

Application Number Title Priority Date Filing Date
UA4460444A UA6099A1 (en) 1988-07-14 1988-07-14 Method for determination of individual sensitivity of patients with bronchial asthma to timaline

Country Status (1)

Country Link
UA (1) UA6099A1 (en)

Similar Documents

Publication Publication Date Title
Rehfeld et al. Gel filtration studies on immunoreactive gastrin in serum from Zollinger-Ellison patients
ES8602774A1 (en) Percutaneous pharmaceutical preparations for external use.
HUT62798A (en) Process for producing pharmaceutical composition with slimming activity
IL110084A (en) Therapeutic preparation for inhalation of insulin and process for its preparation
AU1285592A (en) Methods for increasing extracellular adenosine and for stabilizing mast cells
MY108496A (en) Hypoglycemic thiazolidine diones.
HK15293A (en) Biologically active fragments of the human antihemophilic factor and method for their preparation and pharmaceutical preparations
MY101026A (en) An improved method for administering insulin.
EP0151989A3 (en) Means for the treatment of cardiac diseases
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
ES8608490A1 (en) Pharmaceutical preparations of pinacidal
Sterling et al. The metabolism of 1-aminocyclopentane-1-carboxylic acid in normal and neoplastic tissues
UA6099A1 (en) Method for determination of individual sensitivity of patients with bronchial asthma to timaline
DK0533896T3 (en)
ES8707565A1 (en) Monoclonal antibodies to tissue plasminogen activator derived from human normal cells.
WO1992018536A3 (en) Method for detecting an localizing tissues having neurokinine 1 receptors
RU94022481A (en) Method of estimation of immunogenic activity of bioactive compounds and composition for its realization
Saffhill et al. Terminal deoxynucleotidyl transferase in a case of PH positive infant chronic myelogenous leukamia.
EP0227356A3 (en) The use of depogen in the treatment of restricted blood circulation
UA6102A1 (en) Method for determination of individual sensitivity of patients to kemantane at chronic obstructive bronchitis
Freed Comments on Dr. Liptzin's paper: Erikson's theory from the perspective of women's life cycle.
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
EP0272791A3 (en) Method to monitor and circumvent acquired resistance to chemotherapy in humans
EP0219468A3 (en) 4-methoxy-isophthalic acid derivative having a pharmacological activity in thromboembolic disorders and a process for the preparation thereof
HK127294A (en) Use of 2-amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo [4,5-d] azepin for the preparation of a medicament for the treatment of Parkinson's disease, or of Parkinsonism